Cadrenal TherapeuticsCVKD
13F holders, Q3 2024 (September 30)2holders
$2.27avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding Cadrenal Therapeutics Inc. (CVKD) in their 13F filings. The largest holders were Bank of America Corp. ($68) and Royal Bank of Canada ($0).
- Company
- Cadrenal Therapeutics Inc.
- CUSIP
- 127636207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $68 |
| Exits | 0 | $0 |
Ownership 2 holders
| Bank of America Corp. | 0.00% | New | 5 | $68 |
| Royal Bank of Canada | 0.00% | New | 25 | $0 |
"% of holder's portfolio" is CVKD's weight in each manager's 13F, not the share of Cadrenal Therapeutics Inc. the manager owns.